High SRC-3 levels are associated with breast cancer recurrence [27] and SRC-3 overexpression is associated with tamoxifen and other endocrine therapy resistance in breast cancer patients [27]–[30]. The gene discussed is NCOA3; the disease is breast carcinoma.